Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy.

ABSTRACT:

Objectives

Little is known about the Hymenoptera venom allergy impact on work ability and the effect of venom immunotherapy (VIT) on work. The objective of this study was to evaluate the prevalence and predictors of work disability in patients treated with VIT and the effects of VIT on occupational functioning.

Methods

181 patients, aged 18-71 years, treated with VIT while working, were investigated by questionnaire. Participants were classified into employed and self-employed and, based on work exposure to Hymenoptera, into three risk categories: high risk, occasionally high risk and low risk. Work disability was defined as having to have changed jobs/tasks and/or suffered economic loss because of Hymenoptera venom allergy. Predictors of work disability were assessed in log

SUBMITTER: Paolocci G 

PROVIDER: S-EPMC4127938 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature